YS

Yashwant Singh

Director Director DIN 00834354
DIN 00834354 First appointment Sep 2006 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Yashwant Singh

Data last updated:

Yashwant Singh was a Director at Smark Pharmaceuticals Private Limited (2011–2014) and Director at Evoke Pharmaceuticals Private Limited (from 2006). The companies operate in Chemicals.

DIN 00834354
Primary Designation Director
Industry Chemicals
First Appointment 22 Sep 2006
Oldest Company Age 20 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jun 20111988₹4.2 Lakh (FY 2025)Active
Director22 Sep 20062006Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Evoke Pharmaceuticals Private Limited
Smark Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Yashwant Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yashwant Singh

Yashwant Singh was first appointed on 22 Sep 2006 as Director at Evoke Pharmaceuticals Private Limited. The most recent appointment on record is 03 Jun 2011 at Smark Pharmaceuticals Private Limited.

Yashwant Singh held 2 earlier board appointments: Smark Pharmaceuticals Private Limited (Director, 03 Jun 2011 to 30 Sep 2014); Evoke Pharmaceuticals Private Limited (Director, from 22 Sep 2006).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available